US Patent Issued to Regeneron Pharmaceuticals on Sept. 22 for "Genotyping by sequencing" (New York Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,195, issued on Sept. 22, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"Genotyping by sequencing" was invented by Goncalo Abecasis (Tarrytown, N.Y.), Mathew Barber (Tarrytown, N.Y.) and William Salerno (Tarrytown, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides methods for manufacturing nucleic acid probes for genotyping by sequencing, methods for genotyping a DNA sample by sequencing using a set of nucleic acid probes, and systems for carrying out such methods."

The patent was filed on Nov. 19, 2021, under Application No. 17/531,013.

*For further information, including images, charts and ta...